Impact of interleukin 28B rs12979860 C/T polymorphism on severity of disease and response to treatment in hepatitis delta
Introduction: Pegylated-interferon alpha (Peg-IFN α) is the therapy most commonly used to treat chronic hepatitis delta virus (HDV) infection. In the present study, we planned to investigate effect of IL28B polymorphism on response to Peg-IFN α therapy and disease progression in patients with chroni...
Saved in:
| Main Authors: | Murat Ispiroglu, Ibrahim Halil Bahcecioglu, Ulvi Demirel, Mehmet Yalniz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Journal of Infection in Developing Countries
2017-01-01
|
| Series: | Journal of Infection in Developing Countries |
| Subjects: | |
| Online Access: | https://jidc.org/index.php/journal/article/view/6872 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interleukin 28B polymorphism impact on early HCV kinetics in HCV-infected liver transplant recipients undergoing antiviral therapy
by: V. E. Syutkin, et al.
Published: (2011-12-01) -
Elevated serum levels of adiponectin and interlukin-28B after IFN/RIB therapy in hepatitis C virus-infected patients
by: Kaveh Sadeghi, et al.
Published: (2019-05-01) -
Association Between <i>IL-28B</i> (rs8099917) and <i>IL-28B</i> (rs12979860) with Predisposition to Diseases Related to the HTLV-1: Systematic Review and Meta-Analysis
by: Naomi Cuenca, et al.
Published: (2025-05-01) -
High genetic diversity of hepatitis delta virus in eastern Turkey
by: Yasemin Bulut, et al.
Published: (2014-01-01) -
THE EFFECT OF THE POLYMORPHISM OF THE INTERLEUKIN-28 GENE ON THE EFFECTIVENESS OF THE ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC EPSTEIN-BARR VIRUS INFECTION
by: O.G. Sorokina, et al.
Published: (2017-11-01)